Charles Pamplin III
And finally, drug delivery firm Oxygen Biotherapeutics has hired Col. (ret.) Charles Pamplin III as its new Chief Medical Officer in order to implement the Company’s strategic clinical development plan.
“We believe Dr. Pamplin’s expertise in drug development, the drug approval process, investor outreach, and strategy, as well as his military ties will prove highly beneficial to the company immediately, and over the long term,” said Michael Jebsen, Interim CEO.